z-logo
open-access-imgOpen Access
Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review
Author(s) -
Hu Bo,
Lin JianZhen,
Yang XiaoBo,
Sang XinTing
Publication year - 2020
Publication title -
cell proliferation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.647
H-Index - 74
eISSN - 1365-2184
pISSN - 0960-7722
DOI - 10.1111/cpr.12772
Subject(s) - tumor microenvironment , lipid metabolism , immune system , biology , hepatocellular carcinoma , reprogramming , cancer research , crosstalk , lipid droplet , cancer cell , cancer , immunology , cell , microbiology and biotechnology , biochemistry , genetics , physics , optics
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver with a high worldwide prevalence and poor prognosis. Researches are urgently needed on its molecular pathogenesis and biological characteristics. Metabolic reprogramming for adaptation to the tumour microenvironment (TME) has been recognized as a hallmark of cancer. Dysregulation of lipid metabolism especially fatty acid (FA) metabolism, which involved in the alternations of the expression and activity of lipid‐metabolizing enzymes, is a hotspot in recent study, and it may be involved in HCC development and progression. Meanwhile, immune cells are also known as key players in the HCC microenvironment and show complicated crosstalk with cancer cells. Emerging evidence has shown that the functions of immune cells in TME are closely related to abnormal lipid metabolism. In this review, we summarize the recent findings of lipid metabolic reprogramming in TME and relate these findings to HCC progression. Our understanding of dysregulated lipid metabolism and associated signalling pathways may suggest a novel strategy to treat HCC by reprogramming cell lipid metabolism or modulating TME.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here